SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 352 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $3,448,000 | -36.0% | 30,000 | -13.0% | 0.12% | -9.8% |
| Q3 2014 | $5,390,000 | -5.8% | 34,500 | -25.6% | 0.13% | +6.5% |
| Q2 2014 | $5,720,000 | +186.3% | 46,370 | +140.5% | 0.12% | +210.0% |
| Q1 2014 | $1,998,000 | -1.7% | 19,280 | -14.7% | 0.04% | -9.1% |
| Q4 2013 | $2,032,000 | -65.5% | 22,590 | -74.4% | 0.04% | -31.2% |
| Q3 2013 | $5,898,000 | +197.1% | 88,180 | +193.9% | 0.06% | +10.3% |
| Q2 2013 | $1,985,000 | – | 30,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
| OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
| SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
| Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
| Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
| HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
| CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
| Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |